| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.AMJMED.2008.06.030 |
| P698 | PubMed publication ID | 18954848 |
| P50 | author | James D Chalmers | Q88776588 |
| Aran Singanayagam | Q90027664 | ||
| P2093 | author name string | Adam T Hill | |
| Maeve P Murray | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| P304 | page(s) | 1002-1007.e1 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Prior statin use is associated with improved outcomes in community-acquired pneumonia | |
| P478 | volume | 121 |
| Q30400569 | A Canadian Critical Care Trials Group project in collaboration with the international forum for acute care trialists - Collaborative H1N1 Adjuvant Treatment pilot trial (CHAT): study protocol and design of a randomized controlled trial |
| Q62486815 | A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease |
| Q38670460 | A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days |
| Q38075209 | Acute pneumonia and the cardiovascular system. |
| Q37822666 | Advances in the prevention, management, and treatment of community-acquired pneumonia |
| Q42220049 | Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial. |
| Q37726612 | Clinical features, etiology, and outcomes of community-acquired pneumonia in patients with diabetes mellitus. |
| Q36633471 | Clinical review: Early treatment of acute lung injury--paradigm shift toward prevention and treatment prior to respiratory failure |
| Q85940043 | Community-acquired pneumonia |
| Q34048462 | Community-acquired pneumonia in elderly patients |
| Q95830756 | Coronavirus Disease-2019 (COVID-19) and Cardiovascular Complications |
| Q38105639 | Current treatment of community-acquired pneumonia |
| Q37794958 | Diagnosis, management and prevention of ventilator-associated pneumonia: an update |
| Q38586166 | Do statins prevent acute kidney injury? |
| Q36018451 | Effect of Antiplatelet Therapy on Acute Respiratory Distress Syndrome and Mortality in Critically Ill Patients: A Meta-Analysis |
| Q33752584 | Effect of statin therapy on mortality from infection and sepsis: a meta-analysis of randomized and observational studies |
| Q40237319 | Effect of statins on hospitalization risk of bacterial infections in patients with or without diabetes |
| Q56952861 | Effect of statins on outcomes in immunosuppressed patients with bloodstream infection |
| Q37864327 | Emerging drugs for pneumococcal pneumonia |
| Q36303634 | Emerging roles for cholesterol and lipoproteins in lung disease |
| Q44506811 | Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin |
| Q28249185 | Guidelines for the management of adult lower respiratory tract infections--full version |
| Q91643179 | Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus |
| Q38795745 | Host-directed therapies for infectious diseases: current status, recent progress, and future prospects |
| Q30387466 | Hot topics respiratory infections |
| Q33821978 | Impact of prior statin therapy on the outcome of patients with suspected ventilator-associated pneumonia: an observational study |
| Q38267132 | Impact of statins in outcomes of septic patients: a systematic review |
| Q40390498 | Incidence of Hajj-associated febrile cough episodes among French pilgrims: a prospective cohort study on the influence of statin use and risk factors. |
| Q41248831 | Increased statin prescribing does not lower pneumonia risk |
| Q30383137 | Influenza morbidity and mortality in elderly patients receiving statins: a cohort study. |
| Q39370185 | Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells |
| Q30245459 | Interpretation of the evidence for the efficacy and safety of statin therapy |
| Q47102844 | Linezolid and atorvastatin impact on pneumonia caused by Staphyloccocus aureus in rabbits with or without mechanical ventilation. |
| Q35088200 | Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin. |
| Q34026316 | Mechanisms of neutrophil accumulation in the lungs against bacteria |
| Q30228213 | Meeting the challenge of influenza pandemic preparedness in developing countries |
| Q30399618 | New challenges in community-acquired pneumonia |
| Q34185386 | New modalities in treating pneumococcal pneumonia |
| Q97883476 | Pneumolysin: Pathogenesis and Therapeutic Target |
| Q26853685 | Pneumonia, thrombosis and vascular disease |
| Q26746099 | Potential of immunomodulatory agents as adjunct host-directed therapies for multidrug-resistant tuberculosis |
| Q34573036 | Pre-existing atrial fibrillation and risk of arterial thromboembolism and death following pneumonia: a population-based cohort study |
| Q51158763 | Prior statin use is not associated with improved outcome in emergency patients admitted with infection: a prospective observational study. |
| Q54263540 | Protective Capacity of Statins during Pneumonia Is Dependent on Etiological Agent and Obesity. |
| Q38285835 | Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients |
| Q46139825 | Report of the 'mechanisms of lung injury and immunomodulator interventions in influenza' workshop, 21 March 2010, Ventura, California, USA. |
| Q37870823 | Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality |
| Q37084772 | Risk factors for mortality in patients admitted to intensive care units with pneumonia |
| Q36089280 | Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis |
| Q35511988 | Risk of pneumonia in patients taking statins: population-based nested case-control study |
| Q34559446 | Rosuvastatin for sepsis-associated acute respiratory distress syndrome |
| Q37225099 | Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers |
| Q37612800 | Statin therapy as prevention against development of acute respiratory distress syndrome: an observational study |
| Q33587600 | Statin treatment and mortality in bacterial infections--a systematic review and meta-analysis |
| Q37229844 | Statin use and risk of community acquired pneumonia in older people: population based case-control study |
| Q36117003 | Statin use and the risk of Clostridium difficile in academic medical centres |
| Q35897682 | Statins and acute lung injury: Holy Grail or the next to fail? |
| Q37639928 | Statins for community-acquired pneumonia: current state of the science. |
| Q36369699 | Statins in the critically ill |
| Q55339928 | Statins increase the risk of herpes zoster: A propensity score-matched analysis. |
| Q30492867 | Statins protect against fulminant pneumococcal infection and cytolysin toxicity in a mouse model of sickle cell disease |
| Q59349662 | Statins: a viable candidate for host-directed therapy against infectious diseases |
| Q34531972 | Systematic review and meta-analysis on the association between outpatient statins use and infectious disease-related mortality |
| Q38089090 | The controversy of a wider statin utilization: why? |
| Q34247532 | The effect of rosuvastatin in a murine model of influenza A infection |
| Q34903761 | The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. |
| Q36876210 | The effect of statin therapy on the incidence of infections: a retrospective cohort analysis. |
| Q33882748 | The impact of simvastatin on pulmonary effectors of Pseudomonas aeruginosa infection. |
| Q36633863 | The impact of statin use on pneumonia risk and outcome: a combined population-based case-control and cohort study |
| Q55018714 | The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis. |
| Q34562123 | The role of statins in prevention and treatment of community acquired pneumonia: a systematic review and meta-analysis |
| Q34999389 | Time to intubation is associated with outcome in patients with community-acquired pneumonia |
| Q49791943 | Treatment with atorvastatin provides additional benefits to imipenem in a model of Gram-negative pneumonia induced by Klebsiella pneumoniae in mice |
| Q40364580 | Triggering of acute myocardial infarction by respiratory infection |
| Q57637442 | Using cluster analysis of cytokines to identify patterns of inflammation in hospitalized patients with community-acquired pneumonia: a pilot study |
Search more.